Low-Density-Lipoprotein Cholesterol and Mortality Outcomes Among Healthy Older Adults: A Post Hoc Analysis of ASPREE Trial is a research paper published in The Journals of Gerontology Series A (2023). On theSindex it has a DataRank of 0.513. It has been cited 13 times, with 12 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.396
From this paper's citation signal
Citation Network Contribution
0.117
From 6 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 12 citers.
Royal Australian College of General Practitioners (RACGP)/HCF Research Foundation Research
Grant: HCF2021-11
National Institute on Aging
Grant: U01AG029824
National Institute on Aging
Grant: U19AG062682
National Cancer Institute
Grant: 334047
Randomised double-blind placebo-controlled trial of aspirin in primary prevention of CVD events or dementia in the aged.
National Cancer Institute
Grant: 1127060
ASPREE Completion Project
NIA NIH HHS
Grant: P30 AG024824
National Institutes of Health
Grant: 4U01AG029824-06
ASPirin in Reducing Events in the Elderly
National Institutes of Health
Grant: 5U19AG062682-04
ASPirin in Reducing Events in the Elderly - eXTension
National Health and Medical Research Council
Victorian Cancer Agency
FWCI
3.27
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals